Incyte (INCY) Return on Assets [ROA] (2009 - 2026)
Incyte (INCY) recorded Return on Assets [ROA] of 5.32% in Q3 2026, down 14.24 percentage points from 19.56% a year earlier and down 15.88 percentage points from the prior quarter.
Powered by 
Analysis
Incyte (INCY) Return on Assets [ROA] (2009 - 2026) Analysis & Trends
For FY2025, Incyte reported Return on Assets [ROA] of 20.75%, up 20.22 percentage points from FY2024.
- Annual Return on Assets [ROA] has a five-year change of +29.21 percentage points (FY2020 to FY2025).
- Across earlier years, Return on Assets [ROA] came in at 0.53% in FY2024 (-8.93 pp), 9.47% in FY2023 (+3.14 pp), 6.32% in FY2022 (-16.01 pp) and 22.33% in FY2021 (+30.80 pp).
- The Q3 2026 figure is the lowest quarterly Return on Assets [ROA] since Q1 2025.
- On a year-over-year basis, Return on Assets [ROA] rose in five of the last eight quarters, with an average year-over-year change of +5.48 percentage points.
- Peak year-over-year performance for Return on Assets [ROA] in the last five years was a gain of 29.39 percentage points in Q4 2021, against a drop of 14.77 percentage points in Q4 2022 at the low end.
- Per Business Quant, the preceding three quarters came in at 21.20% (Q2 2026), 20.03% (Q1 2026) and 19.37% (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 19.00% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 8.08% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 7.32% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 1.87% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 9.36% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 9.80% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -7.67% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 2.00% |
| 10 | Incyte | 245.42 Mn | -15.74 Bn | 1.45 Bn | 5.32% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 5.32% |
| Jun 30, 2026 | 21.20% |
| Mar 31, 2026 | 20.03% |
| Dec 31, 2025 | 19.37% |
| Sep 30, 2025 | 19.56% |
| Jun 30, 2025 | 15.05% |
| Mar 31, 2025 | 0.38% |
| Dec 31, 2024 | 0.62% |
| Sep 30, 2024 | 0.67% |
| Jun 30, 2024 | 1.65% |
| Mar 31, 2024 | 10.71% |
| Dec 31, 2023 | 9.07% |
| Sep 30, 2023 | 6.75% |
| Jun 30, 2023 | 6.11% |
| Mar 31, 2023 | 5.57% |
| Dec 31, 2022 | 6.00% |
| Sep 30, 2022 | 16.18% |
| Jun 30, 2022 | 18.22% |
| Mar 31, 2022 | 18.68% |
| Dec 31, 2021 | 20.77% |
API Access
Incyte Return on Assets [ROA] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=INCY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-assets-[roa]", "ticker": "INCY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=INCY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();